InvestorPlace - Stock Market News, Stock Advice & Trading Tips
AeroClean (NASDAQ:AERC) stock is getting a great deal of attention from investors after the company yesterday disclosed that the Food and Drug Administration (FDA) has designated its air purification system as a "Class II Medical Device." AERC stock soared 100% yesterday, but it has fallen over 15% in early trading today.
AeroClean's air purification device, the Purgo, is "proven to eliminate 99.99% of harmful airborne microorganisms, including bacteria, fungi and viruses, like COVID-19," AeroClean explained. The company noted that it sells "air purification and air sanitization technology" to "healthcare facilities, businesses, hospitality venues and government agencies."
Despite the huge rally of AERC stock yesterday, the shares are still changing hands for less than 4% of the name's 52-week high of $117. Also notable is that AeroClean has an enterprise value of $19.5 million, according to Yahoo Finance.
On the other hand, in all of last year, the company only generated $600,000 of revenue. And has a negative earnings-per-share (EPS) of 0.69.
In the last five days, the shares have jumped 88%, but they have tumbled 60% so far this year. AERC stock currently sits in penny stock territory at around $4 a share.
On the date of publication, Larry Ramer did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That's because these "penny stocks" are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com's writers disclose this fact and warn readers of the risks.
Read More: Penny Stocks — How to Profit Without Getting Scammed
The post AERC Stock Is in the Spotlight After AeroClean Receives FDA Clearance appeared first on InvestorPlace.
InvestorPlace-股票市場新聞、股票建議和交易提示
空氣淨化(納斯達克：AERC)股票受到投資者的極大關注，因為該公司昨天披露，美國食品和藥物管理局(FDA)已將其空氣淨化系統指定為“二級醫療設備”。AERC股票昨天飆升100%，但今天早盤下跌超過15%。
AeroClean的空氣淨化設備Purgo被證明可以消除99.99%的空氣中有害微生物，包括細菌、真菌和新冠肺炎等病毒，AeroClean解釋說。該公司指出，它向“醫療機構、企業、接待場所和政府機構”銷售“空氣淨化和空氣消毒技術”。
儘管AERC的股票昨天大幅上漲，但其股票的換手價仍不到該公司52周高點117美元的4%。同樣值得注意的是，AeroClean的企業價值為1950萬美元，根據雅虎財經。
另一方面，在去年全年，該公司只創造了60萬美元的收入。每股收益(EPS)為負0.69。
在過去的五天裡，該公司股價上漲了88%，但今年到目前為止已經下跌了60%。AERC的股票目前處於低價股領域，約為每股4美元。
在本文發表之日，拉裡·拉默並未(直接或間接)持有本文所述證券的任何頭寸。本文表達的觀點是作者的觀點，受InvestorPlace.com和出版指南的約束。
關於細價股和低成交量股票： 除了最罕見的例外，Facebook InvestorPlace不會發布關於市值低於1億美元或每天交易量低於10萬股的公司的評論。這是因為這些“廉價股”經常是詐騙藝術家和市場操縱者的遊樂場。如果我們確實發佈了可能受我們的評論影響的低成交量股票的評論，我們要求 InvestorPlace.com《華爾街日報》的撰稿人披露了這一事實，並警告讀者其中的風險。
閱讀更多資訊： 細價股-如何在不上當的情況下獲利
在AeroClean獲得FDA批准後，AERC股票的帖子首次出現在InvestorPlace上。
